ロード中...
Prospective, double-blind, placebo-controlled randomized trial of cimetidine in gastric cancer
Cimetidine is thought to inhibit suppressor T-lymphocyte function and preliminary evidence from a randomized trial indicated that it might prolong survival for patients with operable and inoperable gastric cancer. The British Stomach Cancer Group conducted a randomized, double-blind, placebo-control...
保存先:
| 主要な著者: | , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Nature Publishing Group
1999
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2362962/ https://ncbi.nlm.nih.gov/pubmed/10604733 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6690457 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|